About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $14.2B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Financiere Des Professionnels Fonds D,Investissement Inc. Portfolio

Follow Financiere Des Professionnels Fonds D,Investissement Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financiere Des Professionnels Fonds D,Investissement Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financiere Des Professionnels Fonds D,Investissement Inc. with notifications on news.